Health Blueprint

Back to Longevity News

News summary

Windward Bio files for IPO at Nasdaq

Source: Startupticker.ch • Published: 26 Oct 2026, 00:00

Summarized by Masters of Longevity from Startupticker.ch.

Windward Bio filed to list common shares on the Nasdaq Global Market.

Windward Bio files for IPO at Nasdaq
Key Takeaways
  • Windward Bio has raised $365 million since launching.
  • WIN378 showed up to a 75-day half-life and improvements.
  • POLARIS-1 and SIRIUS trials were ongoing in asthma and COPD.
Read the full article at Startupticker.ch ↗

Continue exploring

Recommended MoL Picks

MoL PickFrom Metrics to Better LivingEverstride’s May 2026 Consumer Health Market Briefing shows a wellness market moving from products to systems, from tracking to guidance, and from optimization to meaning. The next winners in longevity may not be the companies that measure the most. They may be the ones that help consumers translate health data into a life they actually want to live.MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickSeed Oils and Health: Inflammation, Processing and EvidenceHuman trials, processing risks and long-term health ask different questions. What can seed-oil research tell us—and what remains unresolved?